Hi mudit - yes, even I believe its a noise. This kind of risk can only be taken care via portfolio diversification. Example was just to compare business model of ajanta pharma vs abbott. If the mentioned risk actually happens Ajanta can handle it better than abbott. Or for that matter any regulatory risk specific to India, generics was just example
Subscribe To Our Free Newsletter |